Abstract
For many years, coxsackieviruses (CV) and other enteroviruses have been considered relatively unsophisticated pathogens. They were believed to produce acute infections only and to induce tissue damage and disease exclusively by causing lysis of infected target cells. This contention was based on consistent observations showing that, provided cells are susceptible to infection, CV dramatically damaged or destroyed them, owing to a rapid and virtually complete virus-mediated shutoff of protein synthesis followed by cell lysis in a few hours. Accordingly, necrotic lesions in target organs, such as central nervous system (CNS), pancreas, liver, and myocardium, were viewed solely as the result of local viral replication and cytopathic effect produced by the infecting CV, while immune responses were considered to play only a protective role.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Rager-Zisman, B., and Allison, A. C., 1973, The role of antibody and host cells in the resistance of mice against infection by Coxsackie B-3 virus,J. Gen. Virol. 19:329–338.
Woodruff, J. F., 1979, Lack of correlation between neutralizing antibody production and suppression of coxsackievirus B-3 replication in target organs: Evidence for involvement of mononuclear inflammatory cells in host defences,J. Immunol. 123:31 – 36.
Costanzo-Nordin, M. R., Reap, E. A., O’Connell, J. B., Robinson, J. A., and Scanlon, P. J., 1985, A nonsteroid anti-inflammatory drug exacerbates Coxsackie B-3 murine myocarditis,J. Am. Coll. Cardiol. 6:1078–1082.
Kabiri, M., and Hadaegh, M. D., 1977, Interaction of coxsackievirus B3 and peritoneal exudate cells of adult mice treated with cyclophosphamide,J. Med. Virol. 1:183–191.
Denman, A. M., Rager-Zisman, B., Merigan, T. C., and Tyrrell, D. A. J., 1974, Replication or inactivation of different viruses by human lymphocyte preparations, Infect. Immun. 9:373–376.
Loria, R. M., Kibrik, S., and Broitman, S. A., 1974, Peroral infection with group B coxsackievirus in the adult mouse: Protective functions of gut,J. Infect. Dis. 130:539–543.
Godeny, E. K., and Gauntt, C. J., 1986, Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis,J. Immunol. 137:1695–1702.
Hyöty, H., Huupponen, T., Kotola, L., and Leinikki, P., 1986, Humoral immunity against viral antigens in type 1 diabetes: Altered IgA-class immune response against Coxsackie B4 virus, Acta Pathol. Microbiol. Immunol. Scand. Sect. C 94:83–88.
Welliver, R. C., Drucker, M. M., and Ogra, P. L., 1982, Immunology of enteroviruses, in: Comprehensive Immunology—Immunology of Human Infection. Part II: Viruses and Parasites; Immunodiagnosis and Prevention of Infectious Disease (A. J. Nahmias and R. J. O’Reilly, eds.), pp. 185–203, Plenum Medical, New York.
Bell, E. J., and McCartney, R. A., 1984, A study of Coxsackie B virus infections, 1972–1983,J. Hyg. (Camb.) 93:197–203.
Tilzey, A. J., Signy, M., and Banatvala, J. E., 1986, Persistent Coxsackie B virus specific IgM response in patients with recurrent pericarditis, Lancet 1:1491–1492.
Wolfgram, L. J., Beisel, K. W., Herskowitz, A., and Rose, N. R., 1986, Variations in the susceptibility to coxsackievirus B3-induced myocarditis among different strains of mice,J. Immunol. 136:1846–1852.
Schernthaner, G., Banatvala, J. E., Scherbaum, W., Bryant, J., Borkenstein, M., Schober, E., and Mayr, W. R., 1985, Coxsackie-B-virus-specific IgM responses, complement-fixing islet-cell antibodies, HLA DR antigens, and C-peptide secretion in insulin-dependent diabetes mellitus, Lancet 2:630–632.
Schnurr, D. P., Cao, Y., and Schmidt, N. J., 1984, Coxsackievirus B3 persistence and myocarditis in N:NIH(S) II nu/nu mice,J. Gen. Virol. 65:1197–1201.
Schnurr, D. P., and Schmidt, N. J., 1984, Coxsackievirus B3 persistence and myocarditis in NFR nu/nu and +/nu mice, Med. Microbiol. Immunol. 173:1–7.
Hashimoto, I., Tatsumi, M., and Nakagawa, M., 1983, The role of T lymphocytes in the pathogenesis of Coxsackie virus B3 heart disease, Br. J. Exp. Pathol. 64:497–504.
Robinson, J. A., O’Connell, J. B., Roeges, L. M., Major, E. O., and Gunnar, R. M., 1981, Coxsackie B3 myocarditis in athymic mice, Proc. Soc. Exp. Biol. Med. 166:80–91.
Woodruff, J. F., and Woodruff, J. J., 1974, Involvement of T lymphocytes in the pathogenesis of Coxsackie virus B3 heart-disease,J. Immunol. 113:1726–1734.
Cao, Y., Schnurr, D. P., and Schmidt, N.J., 1984, Monoclonal antibodies for study of antigenic variation in coxsackievirus type B4: Association of antigenic determinants with myocarditic properties of the virus,J. Gen. Virol. 65:925–932.
Griffith, J. S., Katz, S. L., and Moore, M., 1977, Persistent enterovirus infections in agammaglobulinemia, in: Microbiology—1977 (D. Schlessinger, ed.), pp. 488–493, American Society for Microbiology, Washington, D.C.
Johnson, J. P., Yolken, R. H., Goodman, D., Winkelstein, J. A., and Nagel, J. E., 1982, Prolonged excretion of group A coxsackievirus in an infant with agammaglobulinemia,J. Infect. Dis. 146:712.
Woodruff, J. F, and Woodruff, J. J., 1971, Modification of severe coxsackievirus B3 infection in marasmic mice by transfer of immune lymphoid cells, Proc. Nat. Acad. Sci. USA 68:2108–2111.
Cho, C. T., Feng, K. K., McCarthy, V. P., and Lenahan, M. F., 1982, Role of antiviral antibodies in resistance against coxsackievirus B3 infection: Interaction between preexisting antibodies and an interferon inducer, Infect. Immun. 37:720–727.
Kogon, A., Spigland, I., Frothingham, T. E., Elveback, L., Williams, C., Hall, C. E., and Fox, J. P., 1969, The Virus Watch Program: A continuing surveillance of viral infections in metropolitan New York families. VII. Observations on viral excretion, seroimmunity, intrafamilial spread and illness association in Coxsackie and echovirus infections, Am. J. Epidemiol. 89:51–61.
Gauntt, C. J., Paque, R. E, Trousdale, M. D., Gudvangen, R. J., Barr, D. T., Lipotich, G. J., Nealon, T. J., and Duffey, P. S., 1983, Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis, Infect. Immun. 39:851–864.
Sun, S.-C., Burch, G. E., Sohal, R. J., and Chu, K.-C., 1967, Coxsackie B4 viral nephritis in mice and its autoimmune-like phenomenon, Proc. Soc. Exp. Biol. Med. 126:882–885.
Maisch, B., Trostel-Soeder, R., Stechemesser, F., Berg, P. A., and Kochsiek, K., 1982, Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis, Clin. Exp. Immunol. 48:533–545.
Saegusa, J., Prabhakar, B. S., Essani, K., McClintock, P. R., Fukuda, Y., Ferrans, V.J., and Notkins, A. L., 1986, Monoclonal antibody to coxsackievirus B4 reacts with myocardium,J. Infect. Dis. 153:372–373.
Bruserad, G., Stevensen, M., and Thorsby, E., 1985, T lymphocyte responses to coxsackie B4 and mumps virus. II. Immunoregulation by HLA-DR3 and DR4 associated restriction elements, Tissue Antigens 26:179–192.
Paque, R. E., Gauntt, C. J., Nealon, T. J., and Trousdale, M. D., 1978, Assessment of cell-mediated hypersensitivity against coxsackievirus B3 viral induced myocarditis utilizing hypertonic salt-extracts of cardiac tissue, J. Immunol. 120:1672–1678.
Paque, R. E., Gauntt, C. J., and Nealon, T. J., 1981, Assessment of cell-mediated immunity against coxsackievirus B3-induced myocarditis in a primate model (Papio papio), Infect. Immun. 31:470–479.
Woodruff, J. F., 1980, Viral myocarditis, Am. J. Pathol. 101:426–479.
Huber, S. A., Job, L. P., and Auld, K. R., 1982, Influence of sex hormones on Coxsackie B-3 virus infection in Balb/c mice, Cell. Immunol. 67:173–189.
Job, L. P., Lyden, D. C., and Huber, S. A., 1986, Demonstration of suppressor cells in coxsackievirus group B, type 3 infected female Balb/c mice which prevent myocarditis, Cell Immunol. 98:104–113.
Khatib, R., Khatib, G., Chason, J. L., and Lerner, A. M., 1983, Alterations in coxsackievirus B4 heart muscle disease in ICR Swiss mice by anti-thymocyte serum,J. Gen. Virol. 64:231–236.
O’Connell, J. B., Reap, E. A., and Robinson, J. A., 1986, The effects of cyclosporine on acute murine Coxsackie B3 myocarditis, Circulation 73:353–359.
Gudvangen, R. J., Duffey, P. S., Paque, R. E, and Gauntt, C. J., 1983, Levamisole exacerbates coxsackievirus B3-induced murine myocarditis, Infect. Immun. 41:1157–1165.
Lutton, C. W., and Gauntt, C. J., 1986, Coxsackievirus B3 infection alters plasma membrane of neonatal skin fibroblasts,J. Virol. 60:294–296.
Lutton, C. W., Gudvangen, R. J., Nealon, T. J., Paque, R. E, and Gauntt, C. J., 1985, Cellular immune responses in mice challenged with an amyocarditic variant of coxsackievirus B3,J. Med. Virol. 17:345–357.
Huber, S. A., and Lodge, P. A., 1986, Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanism in DBA/2 and BALB/c mice, Am. J. Pathol. 122:284–291.
Friedman, H., Bendinelli, M., and Specter, S. (eds.), 1987, Handbook on Viral Immunosuppression, Dekker, New York, (in press).
Matteucci, D., Paglianti, M., Giangregorio, A. M., Capobianchi, M. R., Dianzani, F., and Bendinelli, M., 1985, Group B coxsackieviruses readily establish persistent infections in human lymphoid cell lines, J. Virol. 56:651–654.
Matteucci, D., Toniolo, A., Conaldi, P. G., Basolo, F., Gori, Z., and Bendinelli, M., 1985, Systemic lymphoid atrophy in coxsackievirus B3-infected mice: Effects of virus and immunopotentiating agents,J. Infect. Dis. 151.1100–1108.
Gauntt, C. J., Trousdale, M. D., LaBadie, D. R. L., Paque, R. E., and Nealon, T., 1979, Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice,J. Med. Virol. 3:207–220.
Belardelli, F., Vignaux, F., Proietti, E., and Gresser, I., 1984, Injection of mice with antibody to interferon renders peritoneal macrophages permissive for vesicular stomatitis virus and encephalomyocarditis virus, Proc. Natl. Acad. Sci. USA 81:602–606.
Bendinelli, M., Ruschi, A., Campa, M., and Toniolo, A., 1975, Depression of humoral and cell-mediated immune responses by coxsackieviruses in mice, Experientia 31:1227–1229.
Bendinelli, M., Matteucci, D., Toniolo, A., Patané, A. M., and Pistillo, M. P., 1982, Impairment of immunocompetent mouse spleen cell functions by infection with coxsackievirus B3,J. Infect. Dis. 146:797–805.
Young, N. A., 1979, Coxsackievirus and echovirus, in: Principles and Practice of Infectious Disease, Vol. II (G. L. Mandell, R. G. Douglas, and J. E. Bennett, eds.), pp. 1104–1120, Wiley, New York.
Kirkpatrick, C. J., Bültmann, B. D., and Gruler, H., 1985, Interaction between enteroviruses and human endothelial cells in vitro. Alterations in the physical properties of endothelial cells plasma membrane and adhesion of human granulocytes, Am. J. Pathol. 118:15–25.
Gururaj, V. J., Marsh, W. W., and Aiyar, S. R., 1984, Fulminant pulmonary coccidioidomycosis in association with Coxsackie B4 infection, Clin. Pediatr. 24:406–408.
Gomez, M. P., Reyes, M. P., Smith, F., Ho, L. K., and Lerner, A. M., 1980, Coxsackievirus B3-positive mononuclear leukocytes in peripheral blood of Swiss and athymic mice during infection, Proc. Soc. Exp. Biol. Med. 165:107–113.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Plenum Press, New York
About this chapter
Cite this chapter
Bendinelli, M., Conaldi, P.G., Matteucci, D. (1988). Interactions with the Immune System. In: Bendinelli, M., Friedman, H. (eds) Coxsackieviruses. Infectious Agents and Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0247-7_6
Download citation
DOI: https://doi.org/10.1007/978-1-4757-0247-7_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-0249-1
Online ISBN: 978-1-4757-0247-7
eBook Packages: Springer Book Archive